TCWP’s Renalytix plc American Depositary Shares RNLX Stock Holding History

TCWP’s Portfolio RNLX Stock Details RNLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-54	Closed	–	–	1857
2022 Q1	$0	Buy	+54	New	+$572	﹤0.01%	1944

Other funds holding RNLX

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Philosophy Capital Management Alamo, California $1.63B AUM 12.69% 1-Year Est. Return

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Lazard Asset Management

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return

TCWP's RNLX Position: Q2 2022 in Review

TCWP sold out of Renalytix plc American Depositary Shares (RNLX) in Q2 2022, closing a stake of 54 shares.

TCWP first reported a position in RNLX in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 31 funds tracked by Wall St. Rank hold RNLX as of Q2 2022.

TCWP reported no remaining Renalytix plc American Depositary Shares position as of Q2 2022 after selling out during the quarter.
TCWP sold 54 Renalytix plc American Depositary Shares shares in Q2 2022.
TCWP first reported a position in Renalytix plc American Depositary Shares in Q1 2022 and held it in 1 quarter.
TCWP's Renalytix plc American Depositary Shares position peaked at $0 in Q1 2022.
31 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.